A new drug increases bone density and reduces the number of fractures in men fighting prostate cancer and in elderly women with bone loss, researchers report in two studies appearing August 11 in the New England Journal of Medicine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.